PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in PDS Biotechnology Corp as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −2 vs. Q4 2025
- Shares held
- 5.05M
- −882.4K (−14.9%) vs. Q4 2025
- Total value
- $3.05M
- −$1.51M (−33.1%) vs. Q4 2025
- New holders
- 7
- 11 more added
- Sold out
- 9
- 9 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PDSB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 52 | $6.78M |
| Q1 2026 | 41 | $3.05M |
| Q4 2025 | 44 | $6.07M |
| Q3 2025 | 47 | $5.32M |
| Q2 2025 | 55 | $9.90M |
| Q1 2025 | 48 | $9.81M |
| Q4 2024 | 52 | $6.94M |
| Q3 2024 | 57 | $16.6M |
| Q2 2024 | 77 | $16.1M |
| Q1 2024 | 72 | $30.2M |
| Q4 2023 | 77 | $41.6M |
| Q3 2023 | 78 | $39.7M |
| Q2 2023 | 80 | $39.9M |
| Q1 2023 | 69 | $46.9M |
| Q4 2022 | 64 | $90.0M |
| Q3 2022 | 47 | $15.4M |
| Q2 2022 | 52 | $19.7M |
| Q1 2022 | 53 | $36.7M |
| Q4 2021 | 66 | $48.3M |
| Q3 2021 | 60 | $101.0M |
| Q2 2021 | 46 | $74.4M |
| Q1 2021 | 32 | $14.3M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding PDS Biotechnology Corp; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,631,089 | $986.8K | 0.00% | +1,631,089 | New |
| Geode Capital Management, LLC | 660,228 | $399.5K | 0.00% | +139,830+26.9% | Added |
| BlackRock, Inc. | 554,048 | $335.2K | 0.00% | +31,837+6.1% | Added |
| Vanguard Fiduciary Trust Co | 307,311 | $185.9K | 0.00% | +307,311 | New |
| Blair William & Co | 300,000 | $181.5K | 0.00% | +50,000+20.0% | Added |
| Renaissance Technologies LLC | 220,800 | $133.6K | 0.00% | +44,100+25.0% | Added |
| Inspirion Wealth Advisors, LLC | 181,995 | $110.1K | 0.01% | +1,500+0.8% | Added |
| Armistice Capital, LLC | 173,605 | $105.0K | 0.00% | −2,660,901−93.9% | Reduced |
| State Street Corp | 133,333 | $80.7K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 110,500 | $66.9K | 0.00% | +105,171+1,973.6% | Added |
| Northern Trust Corp | 108,893 | $65.9K | 0.00% | −34,980−24.3% | Reduced |
| Commonwealth Equity Services, LLC | 90,797 | $54.9K | 0.00% | −106,000−53.9% | Reduced |
| Amussen Hunsaker Associates LLC | 75,022 | $45.4K | 0.00% | +60.0% | Added |
| Bank of New York Mellon Corp | 69,311 | $41.9K | 0.00% | 00.0% | Unchanged |
| Nine Masts Capital Ltd | 67,507 | $40.8K | 0.01% | +67,507 | New |
| Tempus Wealth Planning, LLC | 61,800 | $37.4K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 56,004 | $33.9K | 0.00% | −195,701−77.8% | Reduced |
| XTX Topco Ltd | 36,211 | $21.9K | 0.00% | +1,993+5.8% | Added |
| Two Sigma Securities, LLC | 31,481 | $19.0K | 0.00% | +31,481 | New |
| ACT Capital Management, LLC | 30,000 | $18.1K | 0.01% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 27,664 | $16.7K | 0.00% | +2,000+7.8% | Added |
| Susquehanna International Group, LLP | 22,052 | $13.3K | 0.00% | −16,514−42.8% | Reduced |
| Federation des caisses Desjardins du Quebec | 14,800 | $8.95K | 0.00% | 00.0% | Unchanged |
| Wealth Group, Ltd. | 13,399 | $8.00K | 0.01% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 12,546 | $7.59K | 0.00% | +12,546 | New |
| United Capital Financial Advisers, LLC | 12,000 | $7.26K | 0.00% | +12,000 | New |
| Raymond James Financial Inc | 10,236 | $6.19K | 0.00% | −3,500−25.5% | Reduced |
| Davenport & Co LLC | 10,000 | $6.05K | 0.00% | 00.0% | Unchanged |
| Grandfield & Dodd, LLC | 10,000 | $6.05K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,922 | $2.37K | 0.00% | −1,000−20.3% | Reduced |
| Group One Trading, L.P. | 3,567 | $2.16K | 0.00% | −355−9.1% | Reduced |
| Creative Financial Designs Inc | 3,000 | $1.81K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 2,000 | $1.08K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 655 | $396 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 648 | $392 | 0.00% | 00.0% | Unchanged |
| Basecamp Wealth Advisors LLC | 377 | $228 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 271 | $163 | 0.00% | −18,835−98.6% | Reduced |
| SBI Securities Co., Ltd. | 118 | $71 | 0.00% | +9+8.3% | Added |
| JPMorgan Chase & Co | 19 | $10 | 0.00% | 00.0% | Unchanged |
| Beacon Investment Advisory Services, Inc. | 5 | $4 | 0.00% | +5 | New |
| Royal Bank of Canada | 75 | $0 | 0.00% | +10+15.4% | Added |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −192,556−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −32,099−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −14,703−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −9,393−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,220−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,028−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |